Dr. Langer, the national director of genetic risk evaluation and testing for Compass Oncology and the US Oncology Network, was interviewed for an article in Oregon Jewish Life magazine about Ashkenazi women being under-tested for genetic risk for breast and ovarian cancer. Read the article